Seer (SEER) Other Non-Current Liabilities (2020 - 2026)
Seer (SEER) posted quarterly Other Non-Current Liabilities of $26000.0 for Q1 2026, down 16.13% year-over-year from $31000.0 in Q1 2025, and up 225.0% quarter-over-quarter from $8000.0 in Q4 2025.
Seer (SEER) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Seer's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $26000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 16.13% year-over-year to $26000.0; the TTM figure through Mar 2026 stood at $26000.0 (down 16.13% YoY), while the FY2025 annual figure was $8000.0, down 83.33% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $26000.0, up from $8000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $360000.0 in Q1 2023, with the low at $8000.0 in Q4 2025.
- The 5-year median for Other Non-Current Liabilities is $157000.0 (2023), against an average of $152764.7.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities advanced 5.57% in 2023, then plunged 84.38% in 2025.
- Seer's Other Non-Current Liabilities stood at $320000.0 in 2022, then plunged by 44.06% to $179000.0 in 2023, then tumbled by 73.18% to $48000.0 in 2024, then plunged by 83.33% to $8000.0 in 2025, then jumped by 225.0% to $26000.0 in 2026.
- Business Quant data shows SEER's Other Non-Current Liabilities at $26000.0 in Q1 2026, $8000.0 in Q4 2025, and $10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 173,000.00 |
| Dec 31, 2023 | 179,000.00 |
| Sep 30, 2023 | 157,000.00 |
| Jun 30, 2023 | 174,000.00 |
| Mar 31, 2023 | 360,000.00 |
| Dec 31, 2022 | 320,000.00 |
| Sep 30, 2022 | 319,000.00 |
| Jun 30, 2022 | 323,000.00 |
| Mar 31, 2022 | 341,000.00 |
| Dec 31, 2021 | 341,000.00 |
| Sep 30, 2021 | 402,000.00 |